bc-GenExMiner 3.0: New mining module computes breast cancer gene expression correlation analyses

Database

Volumn 2013, Issue , 2013, Pages

  Jézéquel, Pascal ^a,b   Frénel, Jean Sébastien ^c   Campion, Loïc ^b,c   Guérin Charbonnel, Catherine ^a,b,c   Gouraud, Wilfried ^a,b,c   Ricolleau, Gabriel ^c   Campone, Mario ^b,c  

^a CHU de Nantes   (France)

^b Team 12   (France)

^c Institut de Cancérologie de l'Ouest Site René Gauducheau ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TUMOR PROTEIN;

ARTICLE; BIOLOGY; BREAST TUMOR; CLASSIFICATION; COMPUTER PROGRAM; DATA MINING; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN CHROMOSOME; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MULTIGENE FAMILY; REPRODUCIBILITY; STATISTICS; TUMOR GENE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN; COMPUTATIONAL BIOLOGY; DATA MINING; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MOLECULAR SEQUENCE ANNOTATION; MULTIGENE FAMILY; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; SOFTWARE; STATISTICS AS TOPIC;

MLCS; MLOWN;

EID: 84879381314     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bas060     Document Type: Article

References (23)

1. Jézéquel,P., Campone,M., Gouraud,W. et al. (2012) bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Breast Cancer Res. Treat., 131, 765-774.
2. Ashburner,M., Ball,C.A., Blake,J.A. et al. (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet., 25, 25-29.
3. Lehmann,B.D., Bauer,J.A., Chen,X. et al. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest., 121, 2750-2767.
4. Loo,L.W., Grove,D.I., Williams,E.M. et al. (2004) Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res., 64, 8541-8549.
5. Bergamaschi,A., Kim,Y.H., Wang,P. et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer, 45, 1033-1040.
6. Chin,K., DeVries,S., Fridlyand,J. et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell, 10, 529-541.
7. Wirapati,P., Sotiriou,C., Kunkel,S. et al. (2008) Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res., 10, R65.
8. Jézéquel,P., Campone,M., Roché,H. et al. (2009) 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial. Breast Cancer Res. Treat., 116, 509-520.
9. Loussouarn,D., Campion,L., Leclair,F. et al. (2009) Validation of UBE2C as a prognostic marker in node-positive breast cancer. Br. J. Cancer, 101, 166-173.
10. Lacroix,M. and Leclercq,G. (2004) About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer. Mol. Cell Endocrinol., 219, 1-7.
11. Grinchuk,O.V., Motakis,E. and Kuznetsov,V.A. (2010) Complex sense-antisense architecture of TNAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression. BMC Genomics, 11, 1S9.
12. Dexter,T.J., Sims,D., Mitsopoulos,C. et al. (2010) Genomic distance entrained clustering and regression modeling highlights interacting genomic regions contributing to proliferation in breast cancer. BMC Syst. Biol., 4, 127.
13. Jézéquel,P., Campion,L., Spyratos,F. et al. (2012) Validation of tumour-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumours: a multicentric 2004 national PHRC study. Int. J. Cancer, 131, 426-437.
14. Buness,A., Kuner,R., Ruschhaupt,M. et al. (2007) Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer. Bioinformatics, 23, 2273-2280.
15. Dunbier,A.K., Anderson,H., Ghazoui,Z. et al. (2011) ESR1 is co-expressed with closely adjacent uncharacterized genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet., e1001382.
16. Bernard-Pierrot,I., Gruel,N., Stransky,N. et al. (2008) Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res., 68, 7165-7175.
17. André,F., Job,B., Dessen,P. et al. (2009) Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin. Cancer Res., 15, 441-451.
18. Hu,X., Stern,H.M., Ge,L. et al. (2009) Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol. Cancer Res., 7, 511-522.
19. Pierga,J.Y., Reis-Filho,J.S., Cleator,S.J. et al. (2007) Microarray-based comparative genomic hybridization of breast cancer patients receiving neoadjuvant chemotherapy. Br. J. Cancer, 96, 341-351.
20. Han,W., Jung,E.M., Cho,J. et al. (2008) DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Genes Chromosomes Cancer, 47, 490-499.
21. Horlings,H.M., Lai,C., Nuyten,D.S.A. et al. (2010) Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients. Clin. Cancer Res., 16, 651-663.
22. Hyman,E., Kaurianemi,P., Hautaniemi,S. et al. (2002) Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res., 62, 6240-6245.
23. Pollack,J.R., Sorlie,T., Perou,C.M. et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Sci. USA, 99, 12963-12968.